OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. We bring together leading discovery and development scientists, CMC and regulatory experts,...
Delivered as a Hybrid Event Live In-Person Event March 15-17, 2022 at the San Diego Convention Center, With Live Digital Panel Discussions March 22-24, 2022 Learn how to improve process...
The Fierce Business Development and Licensing (BD&L) Summit for Life Sciences returns LIVE in 2022 bringing together key deal-makers and serving as an open forum for cross-functional business development, due...
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. The 8th Annual Immuno-Oncology 360° Delivers Three...
